有勁基因 TIGS, Taiwan Integrated Genomics Solutions

Yourgene Health is an international molecular diagnostics group which uses the latest advances in DNA analysis technology to develop safer, faster and more accurate genetic screening tests. The Group’s primary focus is on non-invasive prenatal tests (NIPT) for pregnant women - an emerging, multi-billion dollar global market.

In February 2017, Premaitha Health (Manchester, UK) acquired Yourgene Bioscience, a specialist next generation sequencing and bioinformatics company based in Taiwan, to develop Yourgene Health.

The Yourgene Health facility in Taipei is an internationally certified genome core laboratory and a bioinformatics department. The company has extensive experience in conducting experiments and providing scientific research services and has successfully developed multiple bioinformatics analysis methods and constructed databases. Yourgene had participated in the next generation sequencing (NGS) and bioinformatics analysis of Taiwan Biobank

Yourgene Health is located in Taipei, Singapore and Manchester, UK. Its shares trade on the AIM market of the London Stock Exchange (AIM: YGEN). For further information, please visit www.yourgene-health.com.

The acquisition and formation of Yourgene Health allowed both companies to provide more comprehensive non-invasive prenatal test (NIPT) services and technology transfer solutions, as well as founding a globalized DNA diagnostics service platform.